Lenalidomid Devatis

Medicinal product

(Invented) name

Lenalidomid Devatis

Active substance (s)

Lenalidomidas

Strength

25 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2026-06-30

Date of renewal

Documents

Lenalidomid Devatis mokomoji medziaga sveikatos prieziuros specialistams.pdf

Lenalidomid Devatis kontrolinis sarasas sveikatos prieziuros specialistams.pdf

Lenalidomid Devatis recepto patvirtinimo forma.pdf

Lenalidomid Devatis mokomoji medziaga pacientui.pdf

3506_Lenalidomid Devatis 25mg_kiet_kaps_PL_2026-06-30.docx

Lenalidomid Devatis pranesimo apie nestuma forma.pdf

3506_Lenalidomid Devatis 25mg_kiet_kaps_PZ_2026-06-30.docx

Lenalidomid Devatis paciento kortele.pdf

Lenalidomid Devatis vaistines registracijos forma.pdf

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Lenalidomidas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121450	107557	1107557	lizdinė plokštelė	N21		Receptinis	LT/L/26/3506/001	Netiekiama	-	2026-12-01	No	-	-	Download

Stadijos

Data	Stadija
2026-06-30	Registruotas